Evidence map›Paper›PMID 34262618›Full record

ArticleTherapeutic advances in medical oncology2021

Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US: a population-based study calling for further standardization of care.

Lei Huang, Lina Jansen, Rob H A Verhoeven, Jelle P Ruurda, Liesbet Van Eycken, Harlinde De Schutter, Jan Johansson, Mats Lindblad, Tom B Johannesen, Vesna Zadnik and 7 more

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in medical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 6 countries.

Lei HuangDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, Heidelberg, 69120, Germany.ORCID https://orcid.org/0000-0002-4225-9200
Lina JansenDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rob H A VerhoevenDepartment of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.
Jelle P RuurdaDepartment of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Liesbet Van EyckenBelgian Cancer Registry (BCR), Brussels, Belgium.
Harlinde De SchutterBelgian Cancer Registry (BCR), Brussels, Belgium.
Jan JohanssonDepartment of Esophageal and Gastric Surgery, Lund University Hospital, Lund, Sweden.
Mats LindbladDepartment of Clinical Science, Intervention, and Technology (CLINTEC), Division of Surgery, Karolinska University Hospital, Stockholm, Sweden.
Tom B JohannesenRegistry Department, The Cancer Registry of Norway (CRN), Oslo, Norway.
Vesna ZadnikEpidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Tina ŽagarEpidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Margit MägiEstonian Cancer Registry, National Institute for Health Development, Tallinn, Estonia.
Sjoerd M LagardeDepartment of Surgery, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Esther BastiaannetDepartment of Surgical Oncology, Leiden University Medical Center, The Netherlands.
Cornelis J H van de VeldeDepartment of Surgical Oncology, Leiden University Medical Center, The Netherlands.
Petra Schrotz-KingDivision of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, Heidelberg, Baden-Württemberg 69120, Germany.
German Cancer Research Center · DEInstitute of Oncology Ljubljana · SILeiden University Medical Center · NLCancer Registry of Norway · NOErasmus MC · NLKarolinska University Hospital · SELund University · SENational Institute for Health Development · EERadboud University Nijmegen · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe role of resection remains debated in cases of metastatic gastric carcinoma (mGC). Some mGCs are technically resectable. At the population level, the real-world application of resection for mGC remains largely unclear in most Western countries. This large, population-based international investigation aimed to reveal the resection patterns and trends for mGC and the treatment-associated factors in Europe and the US.

methodsData on cases with microscopically-confirmed primary invasive stomach carcinoma with distant metastasis were obtained from the nationwide cancer registries of the Netherlands, Belgium, Norway, Sweden, Estonia, and Slovenia and the US Surveillance, Epidemiology, and End Results-18 database. We calculated age-standardized rates of primary cancer-directed resection and assessed resection trends using linear regression. We investigated associations of treatment with patient and cancer factors using multivariable-adjusted log-binomial regression.

resultsAmong 133,321 patients with gastric cancer, overall, 40,215 cases with mGC diagnosed between 2003-2017 were investigated. Age-standardized resection rates significantly declined over time in the US, Belgium, Sweden, and Norway (by 5-14%). Resection rates greatly differed from 5% to 16% in 2013-2014. Cases with older ages, cardia tumors, or tumors involving adjacent structures were significantly less often operated across most countries. Sex was not significantly associated with resection. Across countries the association patterns and strengths differed largely. With multivariable adjustment, resection rates decreased significantly in all countries except Slovenia and Estonia (prevalence ratio per year = 0.90-0.98), and the decreasing trends were consistently observed in various stratifications by age and location.

conclusionIn Europe and the US, resection patterns and trends largely varied across countries for mGCs, which were mostly less often resected in the early 21st century. Various resection-associated factors were shown, with greatly varying association patterns and strengths. Our report could aid to identify discrepancies in clinical practice and highlight the great need for further clarifying the role of resection in mGCs to enhance standardization of care.

Indexed as

great variationslarge international population-based investigationmetastatic gastric carcinomapatterns and trendstreatment

Identifiers

PMID34262618
PMCPMC8243140
OpenAlexW3176344772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.